Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Finesse Solutions
Finesse Solutions
Activities:
Analysis
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Finesse Solutions offers G3Lite SmartController for single-use bioreactors
Brings the benefits of industrial automation reliability and scalability in affordable package
Manufacturing
Alvotech and Finesse enter into biomanufacturing collaboration
First manufacturing suite expected to be in place by the end of 2015
Manufacturing
ATMI and Finesse Solutions sign distribution agreement
Will allow both companies to offer seamless support for single-use bioreactor systems
Manufacturing
Finesse Solutions moves to new facility in Santa Clara, US
New building includes an expanded Class 10,000 cleanroom for manufacturing single-use sensors
Manufacturing
ATMI and Finesse sign bioprocess reactor agreement
ATMI PadReactor system and Finesse controller technology to be offered as a turnkey system
Subscribe now